Guidelines and Recommendations
This collection is a one-stop shop for guidelines or recommendations developed by CDC, CDC working in collaboration with other organizations or agencies, or by CDC federal advisory committees. These documents contain statements that include recommendations, strategies, and/or information that assists decision makers (such as healthcare providers, federal, state or private agencies, employers, public health officials, or the public) in choosing between alternative courses of action in specific situations. Ultimately, these documents are focused on providing actionable steps to address a specific issue of importance to public health.
The topical areas covered include surveillance, investigation, diagnosis, treatment, intervention, prevention, control, and public health preparedness among others for several diseases and conditions.
Select all docs (Max 200)
Select all docs (Max 200)
1 -
20 of 801 Results
View:
Refine Results
Refine Results:
- Diagnosis (58)
- Evaluation (6)
- Health Education (5)
- Infection Control (1)
- Infectious Disease (1)
- Other (12)
- Prevention and control (1)
- Prevention and Control (586)
- Prevention And Control (4)
- Public Health Preparedness and Response (22)
- Surveillance and Investigation (43)
- Treatment and Intervention (68)
- 2020 (3)
- 2019 (3)
- 2018 (17)
- 2017 (13)
- 2016 (21)
- 2015 (15)
- 2014 (24)
- 2013 (34)
- 2012 (20)
- 2011 (45)
- 2010 (32)
- 2009 (34)
- 2008 (33)
- 2007 (22)
- 2006 (25)
- 2005 (23)
- 2004 (17)
- 2003 (30)
- 2002 (23)
- 2001 (30)
- 2000 (14)
- 1999 (16)
- 1998 (17)
- 1997 (14)
- 1996 (13)
- 1995 (12)
- 1994 (13)
- 1993 (17)
- 1992 (12)
- 1991 (14)
- 1990 (12)
- 1989 (16)
- 1988 (16)
- 1987 (6)
- 1986 (1)
- 1985 (3)
- 1984 (3)
- 1983 (6)
- 1981 (4)
- 1980 (1)
- 1979 (4)
- 1978 (28)
- 1977 (22)
- 1976 (29)
- 1975 (8)
- 1974 (9)
- 1973 (7)
- 1972 (7)
- Acquired Immunodeficiency Syndrome (14)
- administration & dosage (34)
- Adolescent (71)
- Adult (85)
- adverse effects (33)
- Aged (31)
- Animals (33)
- Anthrax (14)
- Anti-HIV Agents (11)
- Antibiotic Prophylaxis (15)
- Antitubercular Agents (10)
- Antiviral Agents (23)
- Bacterial Vaccines (11)
- Bioterrorism (15)
- Cardiovascular Diseases (10)
- Child (89)
- Child, Preschool (71)
- Communicable Disease Control (21)
- Communicable Disease Control/standards (10)
- Contact Tracing (11)
- contraindications (13)
- Cost-Benefit Analysis (11)
- Counseling (14)
- Cross Infection (19)
- diagnosis (15)
- Diphtheria-Tetanus-acellular Pertussis Vaccines (10)
- Diphtheria-Tetanus-Pertussis Vaccine (12)
- Disaster Planning (17)
- Disease Outbreaks (37)
- Disease Outbreaks/prevention & control (26)
- drug therapy (17)
- Environmental Exposure (85)
- Environmental Health (14)
- epidemiology (29)
- Female (60)
- Guidelines as Topic (12)
- Health Education (10)
- Health Personnel (17)
- Health Promotion (13)
- Hepatitis B (10)
- Hepatitis B Vaccines (12)
- HIV Infections (48)
- HIV Infections/prevention & control (13)
- Humans (220)
- Immunization (17)
- Immunization, Secondary (17)
- Immunization Schedule (97)
- Industrial safety (11)
- Infant (80)
- Infant, Newborn (30)
- Infection Control (36)
- Influenza, Human (29)
- Influenza, Human/prevention & control (13)
- Influenza A virus (14)
- Influenza B virus (18)
- Influenza Vaccines (33)
- Licensure (12)
- Male (37)
- Mass Screening (21)
- Meningococcal Infections (11)
- Meningococcal Vaccines (17)
- methods (20)
- Middle Aged (40)
- Mycobacterium tuberculosis (12)
- Occupational Diseases (21)
- Occupational Diseases/prevention & control (73)
- Occupational Exposure (49)
- Occupational Health (12)
- Patient Education as Topic (11)
- Pneumococcal Vaccines (11)
- Population Surveillance (21)
- Practice Guidelines as Topic (18)
- Pregnancy (55)
- Pregnancy Complications, Infectious (26)
- Prevention (12)
- prevention & control (96)
- Public Health (15)
- Public Health Practice (18)
- Rabies (22)
- Rabies Vaccines (20)
- Randomized Controlled Trials as Topic (11)
- Risk (12)
- Risk Assessment (17)
- Risk Factors (41)
- Sexually Transmitted Diseases (20)
- Specimen Handling (12)
- standards (88)
- therapeutic use (23)
- toxicity (13)
- transmission (12)
- Travel (15)
- Tuberculosis (31)
- Vaccination (114)
- Vaccination/standards (18)
- Vaccines, Attenuated (16)
- Vaccines, Combined (11)
- Vaccines, Conjugate (12)
- Vaccines, Inactivated (16)
- Veterinary Medicine (16)
- Young Adult (14)
- Acknowledgements -- Introduction -- Purpose -- Strategies for Identifying At-Risk Groups: Individual Approach -- Strategies for Identifying At-Risk Groups: Population Approach -- Integration of Data. -- Conclusion -- Glossary -- References – Notes. (1)
- American Heart Association (1)
- Centers for Disease Control (U.S.) (1)
- Centers for Disease Control and Prevention (U.S.) (22)
- Environmental Exposure (2)
- FoodCORE (1)
- Hydrocarbons, Chlorinated/poisoning (1)
- Model Aquatic Health Code (3)
- National Institutes of Health (U.S.) (1)
- NIOSH Total Worker Health Program (1)
- Occupational Diseases/prevention & control (3)
- Trichloroethylene/toxicity (1)
- Tungsten/poisoning (1)
- Tungsten/toxicity (1)
- United States (2)
- United States. (1)
- United States. Clinical Laboratory Improvement Amendments of 1988. (1)
- United States. FDA Food Safety Modernization Act. (1)
- United States. Food and Drug Administration. (6)
- United States. Public Health Service. (4)
- Africa (1)
- Africa, Western (1)
- Americas (3)
- Asia (3)
- Australia (1)
- California (1)
- District of Columbia (3)
- Europe (1)
- Florida (3)
- Kosovo (1)
- Latin America (1)
- Maryland (1)
- Mexico (1)
- New Jersey (3)
- New York (2)
- New York City, NY (1)
- New Zealand (1)
- Ohio (1)
- Peru (1)
- South America (1)
- Southwestern United States (1)
- Sweden (3)
- United States (383)
- Virginia (1)
- Yugoslavia (1)